Headquartered in New York, NY Fiscal year ends June NYSE: MSGS msgsports.com
Madison Square Garden Sports Corp. (MSG Sports) is a professional sports company that owns and operates the New York Knicks (NBA) and the New York Rangers (NHL), along with two development league teams — the Westchester Knicks (NBA G League) and the Hartford Wolf Pack (AHL). The company also operates the MSG Training Center in Greenburgh, NY. MSG Sports generates revenue through ticket sales, suite sales, sponsorship and signage, food and beverage and merchandise sales, media rights fees (both national and local), and league distributions. The company is currently pursuing a proposed spin-off to separate its Knicks and Rangers businesses into distinct publicly traded companies, with completion expected by the end of October 2026. Updated
Major corporate breakups are reshaping what shareholders own, but one company is doing it twice and another may hand you cash instead of a second stock. Knowing the difference before these deals…
Pre-Market Stock Futures: Futures are trading lower on this Thursday, but what a difference a month makes: 30 days ago, the worries over inflation and the spiraling situation in Iran were weighing…
Pre-Market Stock Futures: The futures are trading mixed as we approach the end of one of the most volatile and wild trading weeks in recent memory. After starting the day lower on…
Warren Buffett boosts his stake in this tracking stock again, plus notable insider buying from CEOs and an activist investor in the past week.
An offshore driller, a delivery services provider, and a specialty retailer saw the most notable insider buying in the final week of February.
Madison Square Garden Sports Corp. (MSG Sports) is a professional sports company that owns and operates the New York Knicks (NBA) and the New York Rangers (NHL), along with two development league teams — the Westchester Knicks (NBA G League) and the Hartford Wolf Pack (AHL).
24/7 Wall St.'s 12-month price target for MSGS is $549.10, rated Buy. The Wall Street consensus target is $480.67. MSGS price prediction →
